Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 720,850 |
|
|||||
| News | (1) | ||||||
| Day High | 8.15 | Low High |
|||||
| Day Low | 7.64 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Pulmonx Corporation | LUNG | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 2.06 | 27.07% | 9.67 | 18:28:51 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 7.70 | 7.64 | 8.15 | 7.72 | 7.61 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 7,575 | 720,850 | US$ 7.88 | US$ 5,679,534 | - | 7.11 - 14.92 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:34:32 | 56 | US$ 9.53 | USD |
Pulmonx Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 297.51M | 38.54M | - | 68.68M | -60.84M | -1.58 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Pulmonx News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical LUNG Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 7.50 | 8.15 | 7.11 | 7.46 | 435,680 | 2.17 | 28.93% |
| 1 Month | 8.56 | 8.71 | 7.11 | 7.82 | 524,090 | 1.11 | 12.97% |
| 3 Months | 14.48 | 14.92 | 7.11 | 9.65 | 609,110 | -4.81 | -33.22% |
| 6 Months | 8.76 | 14.92 | 7.11 | 10.45 | 430,130 | 0.91 | 10.39% |
| 1 Year | 11.49 | 14.92 | 7.11 | 10.85 | 326,575 | -1.82 | -15.84% |
| 3 Years | 46.90 | 47.57 | 4.07 | 19.09 | 412,531 | -37.23 | -79.38% |
| 5 Years | 38.00 | 69.4779 | 4.07 | 22.70 | 389,999 | -28.33 | -74.55% |
Pulmonx Description
| Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). the company's solutions comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the U.S. and international markets. |
